OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (11)

  1. Li Li, Guang‐an Li, Jun Huang. Evaluation of subclinical left ventricular systolic dysfunction in patients with acute‐phase Kawasaki disease by hematological indices, layer‐specific left ventricular longitudinal strain and global myocardial work. J of Clinical Ultrasound 2023;51:764
    https://doi.org/10.1002/jcu.23442
  2. Michele Maltz-Matyschsyk, Clare K. Melchiorre, Katherine W. Herbst, Alexander H. Hogan, Kristina Dibble, Brandon O’Sullivan, Joerg Graf, Aishwarya Jadhav, David A. Lawrence, William T. Lee, Kyle J. Carson, Justin D. Radolf, Juan C. Salazar, Michael A. Lynes. Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C. Front. Bioeng. Biotechnol. 2023;11
    https://doi.org/10.3389/fbioe.2023.1066391
  3. Mindy Ming-Huey Guo, Ho-Chang Kuo. Promising biomarkers of Kawasaki disease: markers that aid in diagnosis. Expert Review of Molecular Diagnostics 2024:1
    https://doi.org/10.1080/14737159.2024.2432025
  4. Jae Ho Jung, Soyun Hwang, Jae Yun Jung, Joong Wan Park, Eui Jun Lee, Ha Ni Lee, Jin Hee Kim, Do Kyun Kim, Young Ho Kwak. Brain natriuretic peptide as a clinical screening tool for the diagnosis of Kawasaki disease. 2023;102:e34319
    https://doi.org/10.1097/MD.0000000000034319
  5. Xue Fan, Ke Li, Xin Guo, Shengyou Liao, Qi Zhang, Yangkai Xu, Hongtu Cui, Lemin Zheng, Mingguo Xu. Metabolic profiling reveals altered tryptophan metabolism in patients with kawasaki disease. Front. Mol. Biosci. 2023;10
    https://doi.org/10.3389/fmolb.2023.1180537
  6. Óscar Fonseca, Ana S. Ramos, Leonor T. S. Gomes, Maria Salomé Gomes, Ana C. Moreira. New Perspectives on Circulating Ferritin: Its Role in Health and Disease. Molecules 2023;28:7707
    https://doi.org/10.3390/molecules28237707
  7. Huai Wen, Marady Hun, Mingyi Zhao, Phanna Han, Qingnan He. Serum ferritin as a crucial biomarker in the diagnosis and prognosis of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease: A systematic review and meta-analysis. Front. Med. 2022;9
    https://doi.org/10.3389/fmed.2022.941739
  8. Jung Woo Rhim, Beom Joon Kim, Soo-Young Lee, Dae Chul Jeong. Characteristics of Multisystem Inflammatory Syndrome in Children (MIS-C) with Hyperferritinemia. Kawasaki Dis 2023;1
    https://doi.org/10.59492/kd.2023.1.2.e16
  9. Yohei Yamaguchi, Kei Takasawa, Hitoshi Irabu, Kanako Hiratoko, Yosuke Ichigi, Ko Hirata, Yumie Tamura, Miki Murakoshi, Motoi Yamashita, Hisae Nakatani, Masuhiro Shimoda, Taku Ishii, Tomohiro Udagawa, Masaki Shimizu, Hirokazu Kanegane, Tomohiro Morio. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child. Journal of Infection and Chemotherapy 2022;28:814
    https://doi.org/10.1016/j.jiac.2022.01.011
  10. Duck Woo Lee, Hee Joung Choi. Clinical indications for Kawasaki disease in febrile infants aged less than three months. Rheumatol Int 2022;42:891
    https://doi.org/10.1007/s00296-021-05019-7
  11. DiWei Wei, YiDi Zhao, TongQiang Zhang, YongSheng Xu, Wei Guo. The role of LDH and ferritin levels as biomarkers for corticosteroid dosage in children with refractory Mycoplasma pneumoniae pneumonia. Respir Res 2024;25
    https://doi.org/10.1186/s12931-024-02892-1
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd